Advanced search    

Search: authors:"Ryan DeMasi"

2 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis

Alabama at Birmingham. Roy Fleischmann has received consultancies, speaking fees, and honoraria from AbbVie, Amgen, BMS, GSK, Janssen, Lilly, Novartis, Pfizer Inc, Sanofi-Aventis, and UCB. Ryan DeMasi is an

The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review

Pharma Group, which was paid by Pfizer to perform the systematic literature review. Drs Blerina Kola, Ryan DeMasi, and Paola Accossato are employees of Pfizer and own stock in the company. Open Access